This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024
Register
Menu
Register

Mark Pegram, MD
Professor of Medical Oncology at Stanford University School of Medicine
Speaker

Agenda Sessions

  • Lessons Learned from 25 years of HER2 Targeting with Trastuzumab and ADCs Based upon Trastuzumab Such as TDM1 and Enhertu

    , 4:45pm
    View Session

At this event

Prev
Next
David Prihoda
Technical Lead, Discovery Informatics
MSD Czech Republic

See Mark at Antibody Engineering & Therapeutics US

Register